CG:600332 Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is principally engaged in the research and development, manufacturing and sales of Chinese and western patent medicine, chemical active pharmaceutical ingredients (API), natural medicine, biological medicine and chemical API intermediates; wholesale, retail and import and export of western and Chinese pharmaceutical products and medical apparatus; research and development, production and sales of health products, and investment in health industry with healthcare, health management and health nursing, etc. The Company has two operating segments. The Company's Manufacturing segment manufactures and sells western pharmaceutical products, Chinese Patent Medicine (CPM) and health products produced by its manufacturing subsidiaries. Its Trading segment is engaged in the wholesale and retail of western pharmaceutical products, medical apparatus, CPM and Chinese raw medicine; wholesale of goods other than pharmaceutical products.

29.10 CNY
As of 01/28/2022

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Drug Manufacturers-Specialty &
Index country:  China
Country of incorporation:  China
IPO date:  02/07/2001
Stock exchange:    Shanghai Stock Exchange
Exchange country:   China
Market cap:   44,722,872,320 CNY
Current dividend yield:   1.80%
Sedol:      6317179

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy